Remnant cholesterol and systemic inflammation as synergistic predictors of cancer risk: A 16‐year prospective cohort study

RC and systemic inflammation act synergistically and bidirectionally to increase cancer risk, supporting a metabolic-inflammatory axis in carcinogenesis. These findings identify novel, potentially modifiable targets for early cancer risk stratification and prevention.